Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will ...
The company highlights its approach to integrating real-time data analytics with automated PCR infrastructure; The standalone ...